GR3018740T3 - Pharmaceutical packaging unit containing plasminogen activators for multiple-bolus administration - Google Patents

Pharmaceutical packaging unit containing plasminogen activators for multiple-bolus administration

Info

Publication number
GR3018740T3
GR3018740T3 GR960400126T GR960400126T GR3018740T3 GR 3018740 T3 GR3018740 T3 GR 3018740T3 GR 960400126 T GR960400126 T GR 960400126T GR 960400126 T GR960400126 T GR 960400126T GR 3018740 T3 GR3018740 T3 GR 3018740T3
Authority
GR
Greece
Prior art keywords
unit containing
packaging unit
bolus administration
plasminogen activators
pharmaceutical packaging
Prior art date
Application number
GR960400126T
Other languages
Greek (el)
English (en)
Inventor
Ulrich Martin
Reinhard Koenig
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25902885&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3018740(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE19914123845 external-priority patent/DE4123845A1/de
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of GR3018740T3 publication Critical patent/GR3018740T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GR960400126T 1991-04-16 1996-01-19 Pharmaceutical packaging unit containing plasminogen activators for multiple-bolus administration GR3018740T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4112398 1991-04-16
DE19914123845 DE4123845A1 (de) 1991-07-18 1991-07-18 Pharmazeutische verpackungseinheit enthaltend plasminogenaktivatoren zur mehrfachbolusgabe
PCT/EP1992/000851 WO1992018157A1 (de) 1991-04-16 1992-04-15 Pharmazeutische verpackungseinheit enthaltend plasminogenaktivatoren zur mehrfachbolusgabe

Publications (1)

Publication Number Publication Date
GR3018740T3 true GR3018740T3 (en) 1996-04-30

Family

ID=25902885

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960400126T GR3018740T3 (en) 1991-04-16 1996-01-19 Pharmaceutical packaging unit containing plasminogen activators for multiple-bolus administration

Country Status (11)

Country Link
US (3) US5500411A (Direct)
EP (2) EP0580685B1 (Direct)
JP (1) JPH06506459A (Direct)
AT (1) ATE132373T1 (Direct)
CA (1) CA2107476C (Direct)
DE (1) DE59204945D1 (Direct)
DK (1) DK0580685T3 (Direct)
ES (1) ES2082465T3 (Direct)
GR (1) GR3018740T3 (Direct)
HK (1) HK117096A (Direct)
WO (1) WO1992018157A1 (Direct)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0580685B1 (de) * 1991-04-16 1996-01-03 Roche Diagnostics GmbH Pharmazeutische verpackungseinheit enthaltend plasminogenaktivatoren zur mehrfachbolusgabe
US5510330A (en) † 1994-03-25 1996-04-23 Boehringer Mannheim Gmbh Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof.
AU3765897A (en) * 1996-08-14 1998-03-06 Jurgen Brodersen Gram Use of a plasminogen activator for the treatment of pulmonary disorders
JP4155561B2 (ja) * 2000-12-26 2008-09-24 国立大学法人佐賀大学 アレルギー性疾患検査方法
DE10153601A1 (de) * 2001-11-02 2003-05-22 Paion Gmbh DSPA zur Behandlung von Schlaganfall
US7084118B2 (en) * 2002-02-22 2006-08-01 Genentech, Inc. Combination treatment with t-PA variant and low molecular weight heparin
US20070142272A1 (en) * 2003-01-24 2007-06-21 Zlokovic Berislav V Neuroprotective activity of activated protein c independent of its anticoagulant activity
US20100260669A1 (en) * 2004-05-13 2010-10-14 Anthony Joonkyoo Yun Treatment of Seasonal Conditions Through Modulation of the Autonomic Nervous System
WO2006014839A2 (en) * 2004-07-23 2006-02-09 The University Of Rochester Activated protein c inhibits undesirable effects of plasminogen activator in the brain
US8309063B2 (en) * 2005-06-10 2012-11-13 Amcol International Corporation Stable sunscreen compositions containing zinc oxide
TWI482628B (zh) * 2007-10-18 2015-05-01 Lundbeck & Co As H 新穎之血栓溶解病患次群
CN119948064A (zh) * 2022-09-23 2025-05-06 庄伟哲 靶向整合素 αIIbβ3的含组织纤维溶酶原活化剂或其变异体的融合蛋白质及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8508717D0 (en) * 1985-04-03 1985-05-09 Beecham Group Plc Composition
US5234686A (en) * 1985-04-03 1993-08-10 Beecham Group P.L.C. Human tissue plasminogen activator consisting essentially of t-PA residues to 160 to 527, pharmaceutical compositions and methods of treatment
ZW14486A1 (en) * 1985-07-29 1986-10-22 Smithkline Beckman Corp Pharmaceutical dosage unit
JPH02504102A (ja) * 1987-06-30 1990-11-29 ジェネンテク，インコーポレイテッド 血管障害治療のための改良法
US4935237A (en) * 1988-03-21 1990-06-19 Genentech, Inc. Processes for the preparation of t-PA mutants
US5084274A (en) * 1987-11-17 1992-01-28 Scripps Clinic And Research Foundation Inhibition of arterial thrombotic occlusion or thromboembolism
US5342616A (en) * 1988-06-20 1994-08-30 The Wellcome Foundation Limited Method of administering tissue plasminogen activator
GB8814604D0 (en) * 1988-06-20 1988-07-27 Wellcome Found Medicaments
IE69054B1 (en) * 1988-07-20 1996-08-07 Schering Ag Vampire bat salivary plasminogen activators
US4980165A (en) * 1989-01-27 1990-12-25 Genetics Institute, Inc. Pharmaceutical formulations of plasminogen activator proteins
DE3903581A1 (de) * 1989-02-07 1990-08-16 Boehringer Mannheim Gmbh Gewebs-plasminogenaktivator-derivat
US5366730A (en) * 1989-12-20 1994-11-22 Boehringer Mannheim Gmbh Stabilized compositions having human tissue type plasminogen activator enzymatic activity
DE3942143A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh T-pa pro stabilisierung
DE3942141A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh K2p pro-stabilisierung
US5242688A (en) * 1990-12-24 1993-09-07 Eli Lilly And Company Method of treating thromboembolic disorders by administration of diglycosylated t-pa variants
EP0580685B1 (de) * 1991-04-16 1996-01-03 Roche Diagnostics GmbH Pharmazeutische verpackungseinheit enthaltend plasminogenaktivatoren zur mehrfachbolusgabe

Also Published As

Publication number Publication date
US6235279B1 (en) 2001-05-22
JPH06506459A (ja) 1994-07-21
EP0709096A2 (de) 1996-05-01
HK117096A (en) 1996-07-12
EP0580685A1 (de) 1994-02-02
CA2107476C (en) 2007-12-18
DK0580685T3 (da) 1996-03-04
EP0709096A3 (Direct) 1996-05-08
CA2107476A1 (en) 1992-10-17
US5500411A (en) 1996-03-19
ATE132373T1 (de) 1996-01-15
DE59204945D1 (de) 1996-02-15
WO1992018157A1 (de) 1992-10-29
EP0580685B1 (de) 1996-01-03
ES2082465T3 (es) 1996-03-16
US5690931A (en) 1997-11-25

Similar Documents

Publication Publication Date Title
GR3018740T3 (en) Pharmaceutical packaging unit containing plasminogen activators for multiple-bolus administration
ATE101524T1 (de) Hirudin und aktivator des plasminogens enthaltende pharmazeutische wirksame verbindung.
NO20061094L (no) Antistoff samt anvendelse derav til fremstilling av medikamenter til behandling av B-celle-lymfom
HU896546D0 (en) Transdermally usable medical preparations containing gestoden
DE3669103D1 (de) Ibuprofen enthaltendes arzneimittel.
CZ285522B6 (cs) Farmaceutický prostředek pro snížení koncentrace glukosy v krvi
EP0850648A3 (en) Combination of thrombolytically active proteins and anticoagulants and uses thereof
DE59209967D1 (de) Arzneimittel enthaltend aktiviertes Protein C
EP0233013A3 (en) Modified enzyme
DE59811768D1 (de) Pharmazeutische kombinationspräparate enthaltend erythropoietin und modifizierte hämoglobine
EP0356945A3 (de) Verwendung von Plasminogen-Aktivator-Inhibitor (PAI-2) zur Immunsuppression
CA2105888A1 (fr) Utilisation d'un inhibiteur direct de la thrombine pour la fabrication d'un medicament a activite thrombolytique
ATE71535T1 (de) Pharmazeutische zubereitungen.
ZA888250B (en) Human tissue-type plasminogen activator variant
DE68901114D1 (de) Tpa enthaltende arzneimittel.
DK0402208T3 (da) Sammensætning af vitamin A i fysiologisk dosis og forskellige aktive bestanddele med en terapeutisk aktivitet
DK0610655T3 (da) Lægemidler med et indhold af dexpanthenol til topisk anvendelse
GR3006053T3 (Direct)
PH23192A (en) Pharmaceutical compositions having thrombolytic activity
IE880198L (en) Plasminogen activator.
ES2051788T3 (es) Un producto farmaceutico.
GR3029898T3 (en) Use of Etofibrate and pharmaceutical compositions containing etofibrate in the treatment of diabetic angio- and retinopathy.
JPS6434921A (en) Preventive and remedy for thrombosis